Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Products
  • 研究・開発
  • タンパク質解析
  • イムノアッセイ
  • LANCE
  • LANCE Ultra Human Frataxin Detection Kit, 10,000 Assay Points

LANCE Ultra Human Frataxin Detection Kit, 10,000 Assay Points

Lance Ultra Detection Kit
LANCE Ultra Human Frataxin Detection Kit, 10,000 Assay Points
Lance Ultra Detection Kit
Lance Ultra Detection Kit
Lance Ultra Detection Kit

The LANCE® Ultra Human Frataxin Detection Kit is designed for detection and quantitation of human frataxin in cell culture media using a homogeneous TR-FRET (no-wash steps, no separation steps) assay.

View product information
Feature Specification
Application Protein Quantification
Dynamic Range 53.8 - 100,000 pg/mL
Limit of Detection 53.8 pg/mL
Limit of Quantification 308.9 pg/mL
Sample Volume 15 µL

The LANCE® Ultra Human Frataxin Detection Kit is designed for detection and quantitation of human frataxin in cell culture media using a homogeneous TR-FRET (no-wash steps, no separation steps) assay.

View product information
Product variants
Unit Size: 500 assay points
Part #:
TRF1322C
Unit Size: 10,000 assay points
Part #:
TRF1322M
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption, and disposal requirements under European REACH regulations (EC 1907/2006).
Request more information
Lance Ultra Detection Kit
LANCE Ultra Human Frataxin Detection Kit, 10,000 Assay Points
Lance Ultra Detection Kit
Lance Ultra Detection Kit
LANCE Ultra Human Frataxin Detection Kit, 10,000 Assay Points
Lance Ultra Detection Kit
Quick links
  • Variants
  • Product information
  • Resources
  • SDS, COAs, manuals and more
  • Related products
  • Recently viewed
  • Get help

Product information

  • Overview
  • Specifications

Overview

The LANCE® Ultra Human Frataxin Detection Kit is designed for detection and quantitation of human frataxin in cell culture media using a homogeneous TR-FRET (no-wash steps, no separation steps) assay.

  • No-wash steps, no separation steps
  • TR-FRET technology
  • Sensitive detection
  • High reproducibility
  • Faster time-to-results
  • Easy automation
  • 96-well, 384-well, and 1536-well formats

LANCE® and LANCE® (Lanthanide chelate excite) Ultra are our TR-FRET (time-resolved fluorescence resonance energy transfer), homogeneous (no wash) technologies. One antibody of interest is labeled with a donor fluorophore (a LANCE Europium chelate) and the second molecule is labeled with an acceptor fluorophore (ULight™ dye). Upon excitation at 320 or 340 nm, energy can be transferred from the donor Europium chelate to the acceptor fluorophore if sufficiently close for FRET (~10 nm). This results in the emission of light at 665 nm.

Frataxin is expressed as a 210 AA, 23 kDA protein from the FXN gene located on chromosome 9. Upon expression, the FXN protein is directed to the mitochondrion by its 41 AA N-terminal mitochondrial targeting sequence. In the mitochondrion, the protein is cleaved by the mitochondrial processing peptidase (MPP) to its intermediate form of 42 – 210 AA. Later on, MPP cleaves the protein to its mature form of 81-210 AA. Although the function of the FXN protein is not clearly defined, it is thought to be vitally important for Iron-Sulfur cluster biogenesis, heme biosynthesis, and chelation and transportation of iron specifically involved with the mitochondria. The Frataxin protein is the primary culprit for a debilitating neurodegenerative disease called Friedreich’s Ataxia. Due to similarities in the diseases, there is some evidence to suggest that FXN may be involved in other neurodegenerative diseases such as Parkinson’s, Multiple Sclerosis, and Amyotrophic Lateral Sclerosis. This kit has been designed for the detection and quantification of FXN from cell and tissue lysates.

Specifications

Application
Protein Quantification
Automation Compatible
Yes
Brand
LANCE Ultra
Detection Modality
LANCE
Dynamic Range
53.8 - 100,000 pg/mL
Limit of Detection
53.8 pg/mL
Limit of Quantification
308.9 pg/mL
Product Group
Kit
Sample Volume
15 µL
Shipping Conditions
Shipped in Blue Ice
Target
Frataxin
Target Class
Biomarkers
Target Species
Human
Technology
TR-FRET
Therapeutic Area
Neuroscience
Unit Size
10,000 assay points

Resources

Are you looking for resources, click on the resource type to explore further.

  • - すべて -:-:- Any -
  • Guide:-:1
  • Product Info:-:1
1-1 of 1 Resources
Product Info Icon
Product Info
LANCE and LANCE Ultra TR-FRET technology product list

LANCE™ Ultra TR-FRET is a no-wash proximity assay technology that combines the benefits of time resolution (TR) with fluorescence...

Learn more

How can we help you?

We are here to answer your questions.

Contact sales I would like more product information Contact customer care Get technical support
Get Help Illustration Get Help Illustration
Scroll Icon
Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.